RECORDATI UK LTD
Formerly known as EUSA Pharma, the company operates as the UK pharmaceutical wholesale and biotechnology research subsidiary of the Italian group Recordati Industria Chimica E Farmaceutica S.p.A.
Get an alert when RECORDATI UK LTD files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£2.1M
EUR 2,405,000
-6% vs 2024
Net assets
£277M
EUR 323,276,000
+43.3% highest in 3 filed years
Employees
74
+15.6% vs 2024
Profit before tax
£112M
EUR 130,302,000
+95.9% highest in 3 filed years
Net assets
3-year trend · vs Consumer Discretionary median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £128,461,209 | £193,697,385 | £332,686,670 | +71.8% | |
| Operating profit | £44,930,133 | £57,867,124 | £140,013,716 | +142% | |
| Profit before tax | £83,377,625 | £57,026,147 | £111,703,386 | +95.9% | |
| Net profit | £74,551,222 | £42,735,534 | £83,729,104 | +95.9% | |
| Cash | £2,044,578 | £2,193,742 | £2,061,723 | -6% | |
| Total assets less current liabilities | £200,421,775 | £814,865,838 | £750,850,407 | -7.9% | |
| Net assets | £184,960,137 | £193,404,201 | £277,133,305 | +43.3% | |
| Equity | £184,960,137 | £193,404,201 | £277,133,305 | +43.3% | |
| Average employees | 76 | 64 | 74 | +15.6% | |
| Wages | £7,105,872 | £5,154,736 | £8,270,896 | +60.5% | |
| Directors' remuneration | £390,056 | £824,689 | £670,381 | -18.7% |
Figures converted to GBP from EUR at 0.857 per EUR (Frankfurter spot rate) — hover any figure for the original. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Operating margin | 35.0% | 29.9% | 42.1% | |
| Net margin | 58.0% | 22.1% | 25.2% | |
| Return on capital employed | 22.4% | 7.1% | 18.6% | |
| Gearing (liabilities / total assets) | — | 79.6% | 68.4% | |
| Current ratio | 4.72x | 2.22x | 2.12x | |
| Interest cover | 42.51x | 14.47x | 4.48x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 2 times since incorporation
- RECORDATI UK LTD 2024-06-26 → present
- EUSA PHARMA (UK) LIMITED 2015-03-23 → 2024-06-26
- ESSEX BIDCO LIMITED 2014-11-26 → 2015-03-23
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Belluzzo Audit Limited
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors are required to prepare financial statements on the going concern basis, unless it is inappropriate to presume that the Company will continue in business. The directors believe that the adoption of the going concern basis in the preparation of the financial statements is appropriate as, based on current forecasts, the Company has enough funds to continue to trade and meet their liabilities as and when they fall due, over the foreseeable future and at least twelve months following the date of signing the financial statements of the Company for the year ended 31 December 2025.”
Group structure
- RECORDATI UK LTD · parent
- Recordati Netherlands BV 100%
- EUSA Pharma (CH) GmbH 100%
- Recordati Korea, Ltd 100%
- Recordati Argentina S.R.L 100%
Significant events
- “The Company signed new lease agreement on 30th January 2026 with Praxis 258 Breakspear Park Ltd for new office premises at Suite 3B, Third Floor, Breakspear Park, Hemel Hempstead, HP2 4TZ. The contractual term is ten years from 30th January 2026 to 29th January 2036 with a principal rent of £250k a year.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
7 active · 8 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| LONGINOTTI, Luigi | Director | 2022-08-01 | May 1975 | Italian |
| PAGANONI, Davide | Director | 2022-08-01 | Jul 1973 | Italian |
| PALOMBI, Francesco | Director | 2022-08-01 | Oct 1970 | Italian |
| PARENTI, Bruno | Director | 2022-08-01 | Feb 1973 | Italian |
| PESCATORE, Scott Lyons | Director | 2022-03-16 | Mar 1975 | American |
| SOLANKI, Anita | Director | 2026-04-29 | Jun 1978 | British |
| STANDEN, Patrick James | Director | 2022-08-01 | Aug 1970 | British |
Show 8 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| RADIUS COMMERCIAL SERVICES LIMITED | Corporate Secretary | 2017-01-05 | 2018-12-20 |
| JOHNSON, Emma Jane | Director | 2015-01-07 | 2022-11-04 |
| KUMAR, Dev, Dr. | Director | 2017-10-02 | 2022-11-04 |
| MORLEY, Lee Scot | Director | 2015-05-11 | 2021-05-28 |
| MORTON, Bryan Geoffrey, Mister | Director | 2015-03-20 | 2022-03-16 |
| SYKES, Toby George | Director | 2014-11-26 | 2015-03-20 |
| THIEL, Frank Carsten | Director | 2021-06-04 | 2022-03-16 |
| VAINIO, Petri Tapani | Director | 2014-11-26 | 2015-03-20 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Recordati Industria Chimica E Farmaceutica S.P.A | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2022-03-16 | Active |
| Eusa Pharma Holdco 2 (Uk) Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Ceased 2022-03-15 |
Filing timeline
Last 20 of 100 total filings
Material constitutional events — rename, articles re-file, resolution
- 2024-06-26 CERTNM Certificate change of name company PDF
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-05-20 | AA | accounts | Accounts with accounts type full | |
| 2026-05-01 | AP01 | officers | Appoint person director company with name date | |
| 2026-02-03 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-06-26 | AA | accounts | Accounts with accounts type full | |
| 2025-05-20 | AAMD | accounts | Accounts amended with accounts type full | |
| 2025-02-03 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-06-26 | CERTNM | change-of-name | Certificate change of name company | |
| 2024-05-08 | AA | accounts | Accounts with accounts type full | |
| 2024-02-02 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-03-23 | AA | accounts | Accounts with accounts type full | |
| 2023-03-20 | AD02 | address | Change sail address company with old address new address | |
| 2023-03-20 | AD04 | address | Move registers to registered office company with new address | |
| 2023-02-01 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2023-01-09 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2022-11-07 | TM01 | officers | Termination director company with name termination date | |
| 2022-11-04 | TM01 | officers | Termination director company with name termination date | |
| 2022-10-25 | PSC02 | persons-with-significant-control | Notification of a person with significant control | |
| 2022-10-25 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2022-10-12 | AA | accounts | Accounts with accounts type group | |
| 2022-08-11 | AP01 | officers | Appoint person director company with name date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 3
- Capital events
- 0
- Officers appointed
- 1
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.